{"cik":"0001018735","ticker":"NYMXF","name":"NYMOX PHARMACEUTICAL CORP","sic_code":"2835","sic_description":"In Vitro & In Vivo Diagnostic Substances","exchange":"OTC","state_of_incorporation":"","fiscal_year_end":"1231","first_filing_date":"2026-03-27","last_filing_date":"2026-06-03","url":"/sec/cik-0001018735","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001640334-26-001603","form_type":"20-F/A","form_type_family":"annual","doc_date":"2026-09-29","title":"20-F/A — NYMOX PHARMACEUTICAL CORP — 2026-09-29","url_slug":"/sec/cik-0001018735/20-f-a/0001640334-26-001603","edgar_url":"https://www.sec.gov/Archives/edgar/data/1018735/0001640334-26-001603-index.html"},{"accession_number":"0001640334-26-001557","form_type":"20-F/A","form_type_family":"annual","doc_date":"2026-09-16","title":"20-F/A — NYMOX PHARMACEUTICAL CORP — 2026-09-16","url_slug":"/sec/cik-0001018735/20-f-a/0001640334-26-001557","edgar_url":"https://www.sec.gov/Archives/edgar/data/1018735/0001640334-26-001557-index.html"},{"accession_number":"0001640334-26-001515","form_type":"20-F","form_type_family":"annual","doc_date":"2026-09-14","title":"20-F — NYMOX PHARMACEUTICAL CORP — 2026-09-14","url_slug":"/sec/cik-0001018735/20-f/0001640334-26-001515","edgar_url":"https://www.sec.gov/Archives/edgar/data/1018735/0001640334-26-001515-index.html"},{"accession_number":"0001640334-26-001427","form_type":"6-K","form_type_family":"current","doc_date":"2026-08-31","title":"6-K — NYMOX PHARMACEUTICAL CORP — 2026-08-31","url_slug":"/sec/cik-0001018735/6-k/0001640334-26-001427","edgar_url":"https://www.sec.gov/Archives/edgar/data/1018735/0001640334-26-001427-index.html"},{"accession_number":"0001640334-26-001291","form_type":"6-K","form_type_family":"current","doc_date":"2026-08-07","title":"6-K — NYMOX PHARMACEUTICAL CORP — 2026-08-07","url_slug":"/sec/cik-0001018735/6-k/0001640334-26-001291","edgar_url":"https://www.sec.gov/Archives/edgar/data/1018735/0001640334-26-001291-index.html"},{"accession_number":"0001640334-26-000983","form_type":"6-K","form_type_family":"current","doc_date":"2026-06-03","title":"6-K — NYMOX PHARMACEUTICAL CORP — 2026-06-03","url_slug":"/sec/cik-0001018735/6-k/0001640334-26-000983","edgar_url":"https://www.sec.gov/Archives/edgar/data/1018735/0001640334-26-000983-index.html"},{"accession_number":"0001640334-26-000562","form_type":"6-K","form_type_family":"current","doc_date":"2026-03-27","title":"6-K — NYMOX PHARMACEUTICAL CORP — 2026-03-27","url_slug":"/sec/cik-0001018735/6-k/0001640334-26-000562","edgar_url":"https://www.sec.gov/Archives/edgar/data/1018735/0001640334-26-000562-index.html"}],"related_endpoints":{"profile":"/sec/NYMXF/profile","timeline":"/sec/NYMXF/timeline","peers":"/sec/NYMXF/peers","insider_pulse":"/sec/NYMXF/insider-pulse","insider_summary":"/sec/NYMXF/insider-summary","insider_transactions":"/sec/NYMXF/insider-transactions","form144":"/sec/NYMXF/form144","holdings_as_filer":"/sec/NYMXF/holdings","financial_facts":"/sec/NYMXF/financial-facts","derivatives":"/sec/NYMXF/derivatives","officers":"/sec/NYMXF/officers","insider_network":"/sec/NYMXF/insider-network","risk_flags":"/sec/NYMXF/risk-flags","filings":"/sec/NYMXF/filings","cross_topic_dossier":"/api/v1/dossier?ticker=NYMXF"}}